Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jochen Wiesner

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Virulence|December 24, 2010
Antimicrobial peptides: the ancient arm of the human immune systemJochen Wiesner, Andreas Vilcinskas
Expert Opinion on Therapeutic Targets|March 11, 2005
The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugsJochen Wiesner, Frank Seeber
Current Drug Targets|February 3, 2007
Isoprenoid biosynthesis of the apicoplast as drug targetJochen Wiesner, Hassan Jomaa
Parasitology Research|August 26, 2003
Fosmidomycin for the treatment of malariaJochen Wiesner, Steffen Borrmann, Hassan Jomaa
Virulence|January 30, 2013
Methods to identify enzymes that degrade the main extracellular polysaccharide component of Staphylococcus epidermidis biofilmsAnke Gökçen, Andreas Vilcinskas, Jochen Wiesner
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|September 4, 2017
Strategies for the construction of insect P450 fusion enzymesLea Talmann, Jochen Wiesner, Andreas Vilcinskas
Virulence|February 13, 2014
Biofilm-degrading enzymes from Lysobacter gummosusAnke Gökçen, Andreas Vilcinskas, Jochen Wiesner
Archiv Der Pharmazie|November 13, 2007
Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activityJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Structure-activity relationships of novel anti-malarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amidesJochen Wiesner, Katja Kettler, Hassan Jomaa, et al.
Angewandte Chemie (International Ed. in English)|November 13, 2003
New antimalarial drugsJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Virulence|December 24, 2010
Antimicrobial peptides: the ancient arm of the human immune systemJochen Wiesner, Andreas Vilcinskas
Expert Opinion on Therapeutic Targets|March 11, 2005
The plastid-derived organelle of protozoan human parasites as a target of established and emerging drugsJochen Wiesner, Frank Seeber
Current Drug Targets|February 3, 2007
Isoprenoid biosynthesis of the apicoplast as drug targetJochen Wiesner, Hassan Jomaa
Parasitology Research|August 26, 2003
Fosmidomycin for the treatment of malariaJochen Wiesner, Steffen Borrmann, Hassan Jomaa
Virulence|January 30, 2013
Methods to identify enzymes that degrade the main extracellular polysaccharide component of Staphylococcus epidermidis biofilmsAnke Gökçen, Andreas Vilcinskas, Jochen Wiesner
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|September 4, 2017
Strategies for the construction of insect P450 fusion enzymesLea Talmann, Jochen Wiesner, Andreas Vilcinskas
Virulence|February 13, 2014
Biofilm-degrading enzymes from Lysobacter gummosusAnke Gökçen, Andreas Vilcinskas, Jochen Wiesner
Archiv Der Pharmazie|November 13, 2007
Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activityJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Structure-activity relationships of novel anti-malarial agents. Part 3: N-(4-acylamino-3-benzoylphenyl)-4-propoxycinnamic acid amidesJochen Wiesner, Katja Kettler, Hassan Jomaa, et al.
Angewandte Chemie (International Ed. in English)|November 13, 2003
New antimalarial drugsJochen Wiesner, Regina Ortmann, Hassan Jomaa, et al.
Pageof 7